The overall objective is to understand the mechanisms by which activated proto-oncogenes alter normal growth regulatory processes. This will be accomplished by the use of both molecular (i.e. Northern hybridizations and nuclear run-off assays) and cell biological technique (i.e. growth factor requirements for G1 traverse and logarithmic growth. C3H/10t1/2 cells are not stimulated to grow in soft agar by addition of TGFBeta. We have obtained preliminary data demonstrating that transfection of C3H/10T1/2 cells with a mouse c-myc gene linked to an SV40 promoter results in responsiveness to TGFBeta as assayed by colony formation in soft agar. In addition, transfection with an activated H-ras gene results in a transformed cellular morphology, spontaneous growth in soft agar and markedly decreased binding of 125I-labeled TGFBeta. It is proposed that transfection with the activated H-ras gene abrogated proliferative restraints by inappropriate transcriptional and translational activity in growth factor or cell cycle regulated genes normally utilized during controlled proliferation. The myc gene, however, is suggested to be a modulator, rather than inducer of various growth promoting signals. Thus, an optimal (not necessarily appropriate) growth response will result from the synergistic action of both proto-oncogenes. These hypotheses will be addressed by the following specific aims: 1) Determining whether C3H/10T1/2 cells transfected with an activated H-ras and/or myc gene show transcriptional activity of genes known to be under growth factor control; 2) Determining the effects of ras and/or myc gene transfection in C3H/10T1/2 cells on the in vitro production of specific growth factors; 3) Determining the growth factor requirements for G1 traverse and logarithmic growth of ras and/or myc gene transfected cells; and 4) Further characterization of the growth factor specificity for anchorage-independent growth of myc gene transfected C3H/10T1/2 cells. Overall, these studies should increase our knowledge of the mechanisms controlling normal cellular proliferation as well as transformation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA042836-03
Application #
3184447
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1986-09-01
Project End
1989-08-31
Budget Start
1988-09-01
Budget End
1989-08-31
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Fautsch, M P; Eblen, S T; Anders, R A et al. (1995) Differential regulation of p34cdc2 and p33cdk2 by transforming growth factor-beta 1 in murine mammary epithelial cells. J Cell Biochem 58:517-26
Matolcsy, A; Inghirami, G; Knowles, D M (1994) Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma). Blood 83:1363-72
Eblen, S T; Fautsch, M P; Burnette, R J et al. (1994) Cell cycle-dependent inhibition of p34cdc2 synthesis by transforming growth factor beta 1 in cycling epithelial cells. Cell Growth Differ 5:109-16
Inghirami, G; Macri, L; Cesarman, E et al. (1994) Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation. Blood 83:3581-90
Chadburn, A; Knowles, D M (1994) Paraffin-resistant antigens detectable by antibodies L26 and polyclonal CD3 predict the B- or T-cell lineage of 95% of diffuse aggressive non-Hodgkin's lymphomas. Am J Clin Pathol 102:284-91
Inghirami, G; Lederman, S; Yellin, M J et al. (1994) Phenotypic and functional characterization of T-BAM (CD40 ligand)+ T-cell non-Hodgkin's lymphoma. Blood 84:866-72
Inghirami, G; Macri, L; Rosati, S et al. (1994) The Reed-Sternberg cells of Hodgkin disease are clonal. Proc Natl Acad Sci U S A 91:9842-6
Inghirami, G; Szabolcs, M J; Yee, H T et al. (1993) Detection of immunoglobulin gene rearrangement of B cell non-Hodgkin's lymphomas and leukemias in fresh, unfixed and formalin-fixed, paraffin-embedded tissue by polymerase chain reaction. Lab Invest 68:746-57
Chadburn, A; Cesarman, E; Jagirdar, J et al. (1993) CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 72:3078-90
Haber, M M; Liu, J; Knowles, D M et al. (1992) Determination of the DNA content of the Reed-Sternberg cell of Hodgkin's disease by image analysis. Blood 80:2851-7

Showing the most recent 10 out of 21 publications